Drug Discovery News
-
Singapore's Aslan secures $34 mn funding
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Dec, 2015
Singapore: Aslan Pharmaceuticals, Singapore biotech company focused on the development of immunotherapies and targeted ...Read more
-
BI drug gets 'breakthrough therapy designation'
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2014
Singapore: Boehringer Ingelheim has recieved 'breakthrough therapy' designation from US Food & Drug Administration (...Read more
-
Strides subsidiary gets FDA nod for cancer drug
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 04 Sep, 2012
Singapore: Onco Therapies Limited, a wholly-owned subsidiary ofStrides Arcolab, received final abbreviated new drug appl...Read more
-
Glivec inventor wins Szent-Györgyi Prize
Drug Discovery | Influencers | By BioSpectrum Bureau | 0 Comment | 05 Apr, 2013
Singapore: Professor Alex Matter, CEO, Experimental Therapeutics Centre (ETC), A*STAR, Singapore, has been awarded the 8...Read more
-
Taiwan FDA nods Ph II trial of Hep C drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Sep, 2015
Singapore: China based Ascletis has received Taiwan Food and Drug Administration (TFDA) approval to start phase II clini...Read more
-
China's 3SBio to jointly develop mAB with Korea's PharmAbcine
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2015
Singapore: China based 3SBio has entered into an exclusive licensing deal with Korea's PharmAbcine for the development, ...Read more
-
Breast cancer drug market to touch $13.1 bn by 2020'
Drug Discovery | Analysis | By BioSpectrum Bureau | 6 Comment | 24 Jul, 2014
Singapore: Increased use of targeted therapies, along with a greater uptake of branded drugs and rising incidence popula...Read more
-
BMS to develop anti-fibrotic therapies
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Jan, 2015
Singapore: Global pharmaceutical company, Bristol-Myers Squibb, and California Institute for Biomedical Research (Calibr...Read more
-
OSDD starts Youtube competition for TB
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2012
New Delhi: In an innovative approach to spread awareness about the need for researching new drugs for TB, OSDD, India's ...Read more
-
Imugene appoints Mr Charles Walker as CEO
Drug Discovery | Influencers | By BioSpectrum Bureau | 2 Comment | 26 Aug, 2014
Singapore: Australian drug discovery firm, Imugene, has appointed Mr Charles Walker as Chief Executive Officer of Imugen...Read more
-
miRNA tools market clocked $110 mn in 2012: Frost
Drug Discovery | Analysis | By BioSpectrum Bureau | 5 Comment | 09 Sep, 2013
Singapore: Rapid growth in microRNA (miRNA) research over the past two years, which is fuelled by its diagnostic and the...Read more
-
VolitionRx to study cancer detection device in Singapore
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jan, 2015
Singapore: VolitionRx, focused on developing blood-based diagnostic tests for a broad range of cancer types and other co...Read more
-
Japan's Otsuka expands in Australia
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Jan, 2015
Singapore: Japan's firm, Otsuka Pharmaceutical, has established a direct presence in Sydney, Australia, to bring innovat...Read more
-
Global prophylactic HPV vaccine market to reach $2.2bn by 2022'
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Mar, 2014
Singapore: The global prophylactic human papillomavirus (HPV) vaccine market value is forecast to experience moderate gr...Read more
-
Perrigo rejects Mylan's acquisition bid
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2015
Singapore: Irish firm, Perrigo, has declined the acquisition offer from Mylan revalued at USD60 per share in cash and 2....Read more
-
Novartis positive with anti-malaria drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2014
Singapore: Novartis' novel antimalarial drug, KAE609 (cipargamin) has shown efficacy in Phase 2 trial by demonstrating t...Read more
-
Boehringer Ingelheim acquires Pharmaxis' anti-inflammatory drug candidate
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 May, 2015
Singapore: Boehringer Ingelheim has acquired investigational drug PXS4728A from Australia based Pharmaxis, to develop it...Read more
-
Aussie firm gets FDA nod to inititate trial of wet AMD drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Jun, 2015
Singapore: Australia based, Circadian Technologies, through its wholly owned subsidiary Opthea has recieved USFDA approv...Read more
